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The NH2-terminal sequence of steroid receptors is
highly variable between different receptors and in the
same receptor from different species. In this study, a
primary sequence homology comparison identified a 14-
amino acid NH2-terminal motif of the human androgen
receptor (AR) that is common to AR from all species
reported, including the lower vertebrates. The evolu-
tionarily conserved motif is unique to AR, with the ex-
ception of a partial sequence in the glucocorticoid re-
ceptor of higher species. The presence of the conserved
motif in AR and the glucocorticoid receptor and its ab-
sence in other steroid receptors suggests convergent
evolution. The function of the AR NH2-terminal con-
served motif was suggested from a yeast two-hybrid
screen that identified the COOH terminus of the Hsp70-
interacting protein (CHIP) as a binding partner. We
found that CHIP functions as a negative regulator of AR
transcriptional activity by promoting AR degradation.
In support of this, two mutations in the AR NH2-terminal
conserved motif previously identified in the transgenic
adenocarcinoma of mouse prostate model reduced the
interaction between CHIP and AR. Our results suggest
that the AR NH2-terminal domain contains an evolution-
arily conserved motif that functions to limit AR tran-
scriptional activity. Moreover, we demonstrate that the
combination of comparative sequence alignment and
yeast two-hybrid screening using short conserved pep-
tides as bait provides an effective strategy to probe the
structure-function relationships of steroid receptor
NH2-terminal domains and other intrinsically unstruc-
tured transcriptional regulatory proteins.
Steroid receptors depend on multiple domains for their func-
tion as ligand-dependent transcriptional activators. The DNA-
and ligand-binding domains have been studied extensively and
have a high degree of structural and functional conservation.
In contrast, the largely unstructured NH2-terminal domains
(1–3) are highly variable in size and sequence, and the molec-
ular mechanisms that contribute to transactivation are not
well understood. The size of the NH2-terminal region of steroid
receptors increases with evolutionary expansion (4, 5), from
estrogen receptor- (185 amino acid residues) to the glucocor-
ticoid receptor (GR1; 420 residues), androgen receptor (AR; 558
residues), progesterone receptor (B form; 566 residues), and
mineralocorticoid receptor (602 residues). In contrast, tran-
scription factors such as p53, NF-B, and VP16 typically have
transcriptional activation domains of 100 residues.
The importance of the NH2-terminal domain for AR func-
tional activity is attributed largely to activation function-1
(AF1) between amino acid residues 142 and 337 (6). This region
was further resolved into two noncontiguous activation seg-
ments, AF1a and AF1b (7). The functional importance of the
AR NH2-terminal region is supported by the extensive post-
translational modification that occurs in the region, including
phosphorylation (8–10), sumoylation (11), and ubiquitylation
(12, 13). In addition, a conserved region between AR residues
225 and 259 in the region of AF1 was predicted to form an
-helix and to contribute to AR transactivation and was shown
to be a binding site for the general transcription factor TFIIF
(14). Earlier evidence also suggested that the AR NH2-terminal
region contains functional domains involved in transcriptional
repression (15). In contrast, activation function-2 (AF2) in the
AR ligand-binding domain, although highly conserved, has lit-
tle inherent transcriptional activity when assayed in mamma-
lian cells (16).
In this study, we identify sequence 234AKELCKAVS-
VSMGL247 in the human AR NH2-terminal domain, which is
highly conserved in all AR sequences characterized thus far
through multiple fish species. Based on the premise that strict
amino acid sequence conservation indicates a site of critical
function, we investigated the functional importance of human
AR residues 234–247 using a yeast two-hybrid screen. The
COOH terminus of the Hsp70-interacting protein (CHIP) was
identified as a binding partner and was found to contribute to
AR down-regulation.
MATERIALS AND METHODS
Plasmids—The yeast vector pGBT8 was kindly provided by Yue
Xiong (University of North Carolina, Chapel Hill). pCMV-hAR-L237A/
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K239M/V241A/V243A, pCMV-hAR-A234T, and pCMV-hAR-E236G (17)
were created using a double PCR strategy by cloning the fragment into
the AflII and BstEII sites of pCMV-hAR. The yeast bait vector pGBT8-
AR-(220–270) contains the conserved sequence 234AKELCKAVS-
VSMGL247 and was constructed by PCR amplifying the corresponding
region of human AR and inserting the fragment into the EcoRI and
BamHI sites in the pGBT8 vector and was confirmed by DNA sequenc-
ing. GST-AR-(220–270) and GST-AR-(220–270m4), which contains mu-
tations L237A/K239M/V241A/V243A, were created by digesting
pGBT8-AR-(220–270) with and without the mutations with EcoRI and
SalI and cloning the fragment into the EcoRI and SalI sites of pGEX-
5X-1. GST-AR-(220–270)-A234T and GST-AR-(220–270)-E236G were
made by PCR amplifying the corresponding regions of pCMV-hAR-
A234T and pCMV-hAR-E236G, and the fragment was inserted into the
EcoRI and SalI sites of pGEX-5X-1. Gal-AR-(234–247) and Gal-AR-
(229–254), coding for the Gal4 DNA-binding domain fusion protein with
the indicated AR NH2-terminal residues, were created by cloning two
annealed oligonucleotides into the EcoRI and BamHI sites of pGal0.
Gal-AR-(220–270) and Gal-AR-(220–270m4) were created by PCR am-
plifying the corresponding regions of AR and ARm4 (AR with mutations
L237A/K239M/V241A/V243A) and cloning into the EcoRI and BamHI
sites of pGal0. pCMV5-CHIP and pCMV5-CHIPTPR, expressing
CHIP with a deletion of the tetratricopeptide repeat (TPR) domain at
residues 27–147 (see Fig. 3A), were created by digesting pcDNA3-CHIP
and pcDNA3-CHIPTPR with EcoRI and XbaI and ligating the inserts
to the EcoRI and XbaI sites of pCMV5. All PCR-amplified sequences
were verified for the absence of random errors.
Yeast Two-hybrid Screen—A two-hybrid screen of a human testis
library was performed by sequential transformation of bait and library
plasmids as recommended by the manufacturer (Clontech, YEAST-
MAKER Transformation System 2 user’s manual, catalog number
K1606-1). Yeast strain HF7c was transformed with the bait vector
pGBT8-AR-(220–270) and plated onto synthetic medium lacking Trp
with the addition of 0.8 mM 3-amino-1,2,4-triazole to inhibit intrinsic
activity. The yeast clone containing the bait vector was transformed
using 100 g of an amplified human testis MATCHMAKER cDNA
library (BD Biosciences) and plated onto synthetic medium lacking Leu,
Trp, and His with the addition of 0.8 mM 3-amino-1,2,4-triazole. Yeast
colonies grown on synthetic medium lacking Leu, Trp, and His were
further tested for activity using a two-hybrid interaction -galactosid-
ase filter assay performed following the instructions of the manufac-
turer (Clontech, yeast protocols handbook, catalog number PT3024-1,
PR13103). Large fresh colonies were transferred to Whatman No. 5
filter paper, and the filters were immersed in liquid nitrogen for 10 s
and allowed to thaw at room temperature. Freshly prepared Z buffer
containing 60 mM NA2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM
MgSO4, 50 mM 2-mercaptoethanol, pH 7.0, and 0.33 mg/ml 5-bromo-4-
chloro-3-indolyl--D-galactopyranoside (X-gal) was added to the filter
and incubated at room temperature to score blue colonies after 30 min
to overnight. Plasmids from the positive yeast colonies in the -galac-
tosidase filter assay were rescued. Colonies that grew on synthetic
medium lacking Leu gradually lost the bait vector, but not the library
plasmids. The library vector was purified using the Clontech YEAST-
MAKER yeast plasmid isolation kit (catalog number K1611-1).
In Vitro Protein Interaction Assay—GST-AR-(220–270), GST-AR-
(220–270m4), GST-AR-(220–270)-A234T, and GST-AR-(220–270)-
E236G were expressed from pGEX-5X-1 as GST fusion proteins. The
GST fusion proteins were expressed in Escherichia coli XL1-Blue cells
treated with 0.5 mM isopropyl--D-thiogalactopyranoside; extracted in
0.15 M NaCl, 5 mM EDTA, 10% glycerol, 100 M phenylmethylsulfonyl
fluoride, 10 mM dithiothreitol, and 50 mM Tris-HCl (pH 8.0); and incu-
bated with glutathione-agarose beads (Amersham Biosciences) as de-
scribed (18). Full-length CHIP and mutants CHIPTPR, CHIPU, and
CHIP-K30A were expressed from pcDNA3 and in vitro translated in the
presence of 25 Ci of [35S]methionine (PerkinElmer Life Sciences) using
the TNT T7 quick coupled transcription/translation system (Promega).
Washed beads were boiled in SDS-containing buffer. Input lanes con-
tained 30% of the binding reactions.
Transient Transfection Assays—Human hepatocellular carcinoma
HepG2 cells (American Type Culture Collection) were maintained in 5%
CO2 at 37 °C in Eagle’s minimal essential medium (Invitrogen) contain-
ing 10% fetal bovine serum (Gemini Laboratories), 0.1 mM nonessential
amino acids, 1 mM sodium pyruvate, 2 mM L-glutamine, and penicillin
and streptomycin. Cells were plated at 2  105 cells/well on 12-well
tissue culture plates and transfected with the indicated concentrations
of expression vector DNA and 0.1 g of 5xGal4-Luc3 reporter vector
using (per well) 50 l of EC buffer (QIAGEN Inc.), 1 g of enhancer, and
1 l of Effectene. 24 h after transfection, the medium was changed to
serum-free medium, and when appropriate, the indicated hormones
were added. Luciferase activity was determined 24 h later by harvest-
ing cells in 0.22 ml of lysis buffer containing 1% Triton X-100, 2 mM
EDTA, and 25 mM Tris phosphate (pH 7.8) (19). After a 30-min incu-
bation at room temperature, 0.1-ml aliquots were assayed for luciferase
light units using a LumiStar Galaxy multiplate reader luminometer
(BMG Labtechnologies).
To measure inherent transcriptional activation by the AR NH2-ter-
minal conserved motif, Gal4 DNA-binding domain fusion proteins were
expressed in HepG2 cells with the indicated regions of the AR NH2-
terminal domain and the 5xGal4-Luc3 reporter vector. The effect of the
NH2-terminal conserved motif on AR transactivation was determined
in HepG2 cells using full-length AR vectors with the indicated deletions
or mutations and the mouse mammary tumor virus-luciferase (MMTV-
Luc) reporter or the PSA-Enh-Luc reporter (provided by Michael Carey,
University of California, Los Angeles). The influence of CHIP on AR
transcriptional activity was determined in HepG2 cells using (per well)
50 ng of pCMV5 AR expression vector, 25 ng of pCMV5-CHIP and
pCMV5-CHIPTPR vectors, and 0.25 g of MMTV-Luc reporter. Cells
were incubated for 24 h in the absence and presence of the indicated
hormones and assayed for luciferase activity as described above.
In mammalian two-hybrid experiments, human epithelioid cervical
carcinoma HeLa cells were maintained in Eagle’s minimal essential
medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine,
and penicillin and streptomycin. HeLa cells (1.5  105/well of 12-well
plates) were transfected with 0.1 g of 5xGal4-Luc3 reporter and the
indicated AR and CHIP vectors using Effectene as described above.
Immunoblot Analysis—Monkey kidney COS cells were cultured in
Dulbecco’s modified Eagle’s medium containing 10% bovine calf serum
(Hyclone Laboratories), 2 mM L-glutamine, 20 mM HEPES (pH 7.2), and
penicillin and streptomycin in a 5% CO2 incubator at 37 °C. Cells (1.5 
106/10-cm dish) were transfected using DEAE-dextran or the Effectene
reagent kit (QIAGEN Inc.), which included (per 10-cm dish) 0.3 ml of
EC buffer, 16 l of enhancer, 10 l of Effectene, and 1 ml of medium
added to 7 ml of fresh medium. After transfection, the medium was
replaced with serum-free medium with and without 50 nM dihydrotes-
tosterone (DHT). The next day, cells were washed with cold phosphate-
buffered saline and harvested in 1 ml of phosphate-buffered saline.
After centrifugation at 5000 rpm at 4 °C, cells were suspended in 0.1 ml
of lysis buffer containing 0.15 M NaCl, 0.5% Nonidet P-40, 50 mM NaF,
1 mM dithiothreitol, 50 mM Tris-HCl (pH 7.5), 1 mM phenylmethylsul-
fonyl fluoride, and protease inhibitor mixture (Sigma) and incubated for
1 h at 0 °C. After centrifugation at 12,000 rpm for 15 min at 4 °C, the
supernatant protein concentration was determined using the Bio-Rad
assay. Samples (10 g of protein/lane) were separated on 10 or 8–16%
acrylamide gels containing SDS. After electrophoresis, gel proteins
were electrophoretically transferred to nitrocellulose membranes. The
blots were incubated with 1 g/ml rabbit antibody AR32, raised against
an AR NH2-terminal peptide, or with a 1:500 dilution of mouse anti-
Gal4 DNA-binding domain IgG2a (sc-510, Santa Cruz Biotechnology).
Immunoreactive bands were visualized using chemiluminescence
(SuperSignal Western Dura extended duration substrate, Pierce).
Immunocytochemistry—COS cells (1.25  106/well) were transfected
in 12-well tissue culture plates, with each well containing a 0.15-mm
thick cover glass (Fisher). Cells were transfected using Effectene as
described above with 0.2 g of pCMV-hAR and pCMV5-FLAG-CHIP
and treated with and without 100 nM DHT 24 and 48 h after transfec-
tion. Cells were fixed with freshly prepared 3% paraformaldehyde,
permeabilized with 0.2% Triton X-100, blocked with 0.5% bovine serum
albumin as described (20), and incubated for 1 h with primary antibod-
ies: mouse anti-FLAG monoclonal antibody M2 (1:250 dilution; Sigma)
and rabbit anti-AR polyclonal antibody 3510 (1:250 dilution; Abcam,
Inc.). After several washes with phosphate-buffered saline, cells were
incubated for 30 min with secondary antibodies: TRITC-conjugated
AffiniPure donkey anti-mouse IgG (1:50 dilution; Jackson ImmunoRe-
search Laboratories, Inc.) and fluorescein isothiocyanate-conjugated
AffiniPure donkey anti-rabbit IgG (1:50 dilution; Jackson Immuno-
Research Laboratories, Inc.). The cover glasses were mounted on slides
using DakoCytomation fluorescent mounting medium (Fisher) and
viewed using a Zeiss LSM 210 confocal microscope.
RESULTS
Identification of an AR NH2-terminal Conserved Motif—
Comparison of AR NH2-terminal sequences from human to
lower vertebrates shows that much of the region is not con-
served (Fig. 1A). This is despite the important functional role of
the AR NH2-terminal domain in transactivation (6). Among the
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poorly conserved regions are the previously reported AR trans-
activation subdomains AF1a (rat AR residues 154–167 and
human AR residues 173–186) and AF1b (rat AR residues 295–
359 and human AR residues 297–361), which are critical for
transcriptional activity (7). Lack of sequence conservation in
these regions is surprising and suggests that the NH2-terminal
FIG. 1. Alignment of the AR NH2-terminal amino acid sequence from different species. A, AR sequences were obtained from the
GenBankTM/EBI Data Bank with the following accession numbers: human AR, M20132 and J03180; Norway rat AR, J05454; Xenopus laevis
African clawed frog AR, U67129; goldfish AR, AY090897; fathead minnow, AY004868; Japanese eel AR-, AB023960; Japanese eel AR-,
AB025361; rainbow trout AR-, AB012095; rainbow trout AR-, AB012096; Nile tilapia AR-, AB045212; red sea bream AR, AB017158;
Haplochromis burtoni cichlid fish AR, AF121257 and AY082342; and Nile tilapia AR-, AB045211. Amino acid residues conserved by amino acid,
charge, or structure are shown in red, and partially conserved residues are shown in blue. The AR FXXLF motif is at residues 23–27, and the
NH2-terminal conserved motif is at residues 234–247. Amino acid positions are based on the human AR sequence (22). The region shown is human
AR NH2-terminal residues 1–543. B, shown is an amino acid sequence alignment of the AR NH2-terminal conserved motif and flanking sequence,
the AR consensus sequence, and the corresponding homologous sequence in GR. Sequences shown were extracted from the sites listed above and
include human GR (X03225 and M10901) and X. laevis African clawed frog GR (X72211). Conserved residues are shown in orange-red, and partially
conserved residues are shown in maroon. The human AR phosphorylation site Ser256 (10) and AR mutations from TRAMP prostate cancer tumors
(A234T and E236G) are indicated. Shown are amino acid sequences corresponding to human AR residues 226–257 with numbering as previously
reported (22) and human GR residues 67–98 (72).
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domain evolved with its interacting partners. In contrast, sev-
eral short regions of the AR NH2-terminal region show a high
degree of sequence conservation. The previously described
FXXLF motif at human AR NH2-terminal residues 23–27 (18,
21) is conserved as (F/Y)Q(N/S)(L/V)F from lower vertebrates
through primates, although some species of fish seem to lack
the NH2-terminal 5-coding region of the AR gene that includes
the FXXLF motif (Fig. 1A). Absence of the extreme NH2-termi-
nal region could reflect incomplete sequence analysis or that
certain species of fish have yet to evolve the AR FXXLF motif.
An evolving FXXLF motif during vertebrate expansion is con-
ceivable since the WXXLF motif at human AR residues 433–
437, which contributes to the FXXLF motif-mediated AR NH2-
and COOH-terminal interaction (18), is conserved from pri-
mates to Xenopus, but not in fish and other lower vertebrates
(Fig. 1A).
Another AR NH2-terminal region that shows striking se-
quence conservation across species is positioned at human AR
residues 234–247 (Fig. 1A) with the consensus sequence
234A(K/R/Y)EL(C/S)KAVSVS(M/L)GL247 (Fig. 1B), numbered
according to the human AR sequence of Lubahn et al. (22) and
the AR mutation data base.2 Sequence conservation of hydro-
phobic residues in the region was noted previously (14). Also
notable is Ser256-Pro257 since Ser256 was shown previously to be
phosphorylated in human AR (10). Ser256 and Pro257 are not
conserved; but remarkably, the negatively charge residues Asp
and Glu most often replace Ser256 in lower species (Fig. 1, A
and B), suggesting that a negative charge at this position is
important for AR function.
Sequence conservation of AR NH2-terminal residues 234–
247 suggests a conserved motif for the AR gene family. A search
of the protein sequence data base supports this, with one ex-
ception. GR from human and Xenopus, but not GR from fish,
contains sequence 77DLSKAVSLSMGL88 at human GR resi-
dues 77–88, which is homologous to 12 of the 14 residues in the
AR NH2-terminal conserved motif (Fig. 1B). The closer evolu-
tionary distance between AR and the progesterone receptor
compared with AR and GR (4) and the absence of the conserved
motif in the progesterone receptor suggest that AR and GR
acquired the sequence independently for a common function by
convergent evolution.
Analysis of the predicted order and disorder composition of
the AR NH2-terminal domain using the PONDR Protein Dis-
order Predictor3 indicates that the FXXLF motif and the AR
NH2-terminal conserved motif form short structurally ordered
regions as indicated by PONDR scores of 0.1. Each motif is
predicted to form an amphipathic -helix, indicating the pres-
ence of short structured segments in an NH2-terminal region
that is otherwise predicted to be largely unstructured.
Intrinsic Activity of the AR NH2-terminal Conserved Motif—
We tested for the presence of transcriptional activity inherent
to the AR NH2-terminal conserved motif by expressing Gal4
DNA-binding domain-AR fusion proteins in mammalian cells
(Fig. 2A). The NH2-terminal conserved motif residues 234–247
lacked activity, but a low level of activity was detectable when
the sequence was extended in Gal-AR-(229–254). A larger frag-
ment, Gal-AR-(220–270), elicited 20% the activity of the AR
NH2-terminal domain in Gal-AR-(1–503). When mutations at
four residues (L237A/K239M/V241A/V243A) were introduced
into the NH2-terminal conserved motif in Gal-AR-(220–270)
(Gal-AR-(220–270m4)) (Fig. 2A), the transcriptional response
was reduced to background levels. Expression levels of the
Gal-AR fusion proteins were similar as determined by immu-
noblotting (Fig. 2C, left panel).
The results suggest that although the NH2-terminal con-
served motif itself lacks intrinsic transcriptional activity, a
larger region that includes flanking sequence of the conserved
motif induces a transcriptional response that depends on resi-
dues within the AR NH2-terminal conserved motif. The flank-
ing region may therefore be necessary for proper folding or
presentation of the NH2-terminal conserved motif.
Contribution of the core conserved motif to AR transcriptional
activity was investigated further by testing several mutants of
full-length AR. Deletion of region 220–270 (AR220–270) caused
a 50% decrease in AR transcriptional activity using the MMTV-
Luc and PSA-Enh-Luc reporter vectors (Fig. 2B), confirming the
importance of the region for AR activity. The decrease in tran-
scriptional activity by AR220–270 and additional mutants was
independent of AR expression levels (Fig. 2C, right panel). De-
leting only the NH2-terminal conserved motif (AR234–247)
caused less of a decrease in activity, and the decrease was similar
to that seen with ARm4. Mutating the flanking Ser256 (Fig. 1B) to
alanine to inhibit phosphorylation at this previously reported AR
phosphorylation site (10) or to aspartic acid to mimic the negative
charge of a phosphate group had no effect on the AR transcrip-
tional response. The results suggest that the AR NH2-terminal
conserved motif and closely flanking sequence contribute to AR
transactivation.
AR NH2-terminal Conserved Motif Interaction with CHIP—
The high sequence conservation of the AR NH2-terminal motif
in AR gene evolution, its predicted structure, and evidence for
a role in AR transcriptional activation led us to perform a yeast
two-hybrid screen using a 51-amino acid residue fusion peptide
as bait to probe a human testis cDNA library. Yeast strain
HF7c was initially transformed with pGBT8-AR-(220–270),
coding for the Gal4 DNA-binding domain and human AR resi-
dues 220–270. In agreement with the transcriptional response
seen with Gal-AR-(220–270) in mammalian cells, the addition
of 0.8 mM 3-amino-1,2,4-triazole was required to reduce intrin-
sic activity of pGBT8-AR-(220–270). Screening 106 clones of an
amplified library revealed 138 positive clones that grew on
synthetic medium lacking Leu, Trp, and His. Of these, 48
clones were positive in a -galactosidase filter assay performed
in yeast. Sequence analysis revealed five identical clones cod-
ing for CHIP. The clones coded for CHIP residues 20–303,
representing full-length CHIP lacking the first 19 NH2-termi-
nal amino acids. That the interaction was specific was sug-
gested by a parallel screen of the same library using a similarly
sized AR fragment from a different region of the AR NH2-
terminal domain. In this case, none of the positive clones that
grew on synthetic medium lacking Leu, Trp, and His coded for
CHIP.4
CHIP is a U-box-containing ubiquitin-protein isopeptide li-
gase (E3) (23–26) that interacts with heat shock proteins
Hsp70 and Hsp90 through its NH2-terminal TPR domain (Fig.
3A) and has been reported to cause ubiquitylation of AR (13).
To further investigate the role of the AR NH2-terminal con-
served motif in the AR and CHIP interaction, we tested several
AR mutants in a mammalian two-hybrid assay using a Gal-
CHIP-(20–303) fusion protein. Deletion of AR residues 220–
270 (AR220–270) strongly reduced the interaction with CHIP
(Fig. 3B), supporting the role of the NH2-terminal conserved
motif region in the AR interaction with CHIP. A small portion
of this reduction was attributed to the slight decrease in back-
ground AR activity that resulted from the deletion of residues
220–270, in agreement with the results of Fig. 2 (A and B)
showing that residues 220–270 harbor a transcriptional acti-
vation function. The background AR activity evident upon co-
2 Available at ww2.mcgill.ca/androgendb/data.htm.
3 Available at www.pondr.com/PONDR/pondr.cgi. 4 S. Bai, B. He, and E. M. Wilson, unpublished data.
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FIG. 2. Transcriptional activity of the AR NH2-terminal conserved motif. A, the transcriptional activity of the AR NH2-terminal
conserved motif and flanking sequence was determined by expressing Gal4 DNA-binding domain fusion proteins with no insert (GAL4-DBD) or
with AR fragments in Gal-AR-(1–503), Gal-AR-(234–247), Gal-AR-(229–254), Gal-AR-(220–270), and Gal-AR-(220–270m4). Activity was deter-
mined in HepG2 cells using 50 ng of pGal vector and 0.1 g of 5xGal4-Luc3 reporter vector. Cells were transfected using Effectene as described
under “Materials and Methods.” The transcriptional response is indicated in optical light units and error and are representative of three
independent experiments. B, shown is the effect of the NH2-terminal conserved motif region on AR transactivation. HepG2 cells were transiently
transfected as described under “Materials and Methods” with 0.25 g of MMTV-Luc or 0.25 g of PSA-Enh-Luc together with 50 ng of pCMV-hAR
with wild-type sequence (WT), with deletion of the conserved region (AR220–270 and AR234–247), with the four-residue mutation in the
NH2-terminal conserved motif (ARm4 (m4)), and with mutations S256A (SA) and S256D (SD) at an AR phosphorylation site. C, shown are
immunoblots of AR mutants. Wild-type and mutant Gal-AR (10 g/10-cm dish) and pCMV5-AR plasmids (2 g/dish) were transiently expressed
in COS cells (1.8  106/10 dish) using DEAE-dextran in the absence of added androgen. For the Gal-AR vectors, cells were incubated in
serum-containing medium with 1 M MG132 proteasome inhibitor for 1 h at 37 °C prior to harvest. Protein extracts (10 g/lane) were analyzed
using anti-Gal4 DNA-binding domain antibody (left panel) for the Gal-AR fusion proteins tested for transcriptional activity in A or antibody AR32
(right panel) for the AR mutants tested for transcriptional activity in B.
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FIG. 3. Interaction of CHIP with the AR NH2-terminal conserved motif. A, schematic diagram of full-length CHIP (303 amino acids)
containing the NH2-terminal TPR domain at residues 27–147, which interacts with Hsp70 and Hsp90, and the COOH-terminal U-box domain at
residues 231–288, which imparts E3 (ubiquitin-protein isopeptide ligase (Ub ligase)) activity (23, 24). Lys30 is required for the interaction between the
TPR domain and Hsp70Hsp90 (C. Patterson, unpublished data). The results from GST affinity binding studies shown in C indicate that the TPR and
U-box domains of CHIP are required for interaction with AR (shown by the bracket). B, interaction of CHIP with full-length AR in a mammalian
two-hybrid assay. The assay was performed in HeLa cells using full-length wild-type AR, AR220–270, AR234–247, and ARm4 and cotransfected
with the parent pGal0 empty plasmid (GAL 0) or Gal-CHIP-(20–303) (GAL CHIP). HeLa cells were transfected using 10 ng of AR, 50 ng of Gal
expression plasmid, and 0.1 g of 5xGal4-Luc3 in 12-well plates using Effectene as described. Optical light units reflect luciferase activity and error
and are representative of three independent experiments. C, in vitro interaction between CHIP and the AR NH2-terminal conserved motif.
35S-Labeled
full-length wild-type CHIP (WT; lanes 1, 5, and 9), CHIPTPR (lacking the TPR domain; lanes 2, 6, and 10), CHIPU (lacking the U-box domain; lanes
3, 7, and 11), and CHIP-K30A (lanes 4, 8, and 12) were incubated with GST (GST0; lacking AR sequence; lanes 1–4), GST-AR-(220–270) (containing
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expression of the pGal0 empty vector results from a cryptic
androgen response element in the 5xGal4-Luc3 reporter (19).
Deleting the NH2-terminal conserved motif in AR234–247 or
introducing the multiple mutations L237A/K239M/V241A/
V243A into AR (ARm4) did not decrease background AR tran-
scriptional activity and reduced (but did not eliminate) the AR
and CHIP interaction.
The results support a role for the NH2-terminal conserved
motif in the AR and CHIP interaction, but also suggest that
additional direct or indirect interactions occur between AR and
CHIP. One possible interaction site is the AR ligand-binding
domain, which was shown to bind the Hsp70Hsp90 heterocom-
plex (27, 28), and Hsp70Hsp90 interacts with CHIP (23). A
recent study demonstrating that CHIP functions as a dimer
provides a basis for this type of interaction (29).
GST in Vitro Adsorption Assay—To confirm a direct interac-
tion between the AR NH2-terminal conserved motif and CHIP,
GST affinity matrix binding assays were performed. Wild-type
GST-AR-(220–270) and GST-AR-(220–270m4) were expressed
in E. coli, purified, and incubated with 35S-labeled in vitro
translated full-length CHIP and several CHIP mutants. A
strong interaction was evident between GST-AR-(220–270)
and 35S-labeled CHIP that was not detected using the pGST0
empty vector control (Fig. 3C, lanes 1 and 5). The AR interac-
tion with CHIP was eliminated by deleting the CHIP TPR
domain (lane 6), by deleting the CHIP U-box domain (lane 7), or
by introducing a K30A mutation into the CHIP TPR domain
(lane 8). Lys30 is highly conserved in the TPR domain (30) and
was shown to be required for the interaction between the CHIP
TPR domain and Hsp70 or Hsp90.5
Two AR mutations identified in the transgenic adenocarci-
noma of mouse prostate (TRAMP) model for prostate cancer,
E236G and A234T (17), also reduced the AR and CHIP inter-
action by 43 and 16%, respectively (Fig. 3D). In contrast, no
decrease in the AR and CHIP interaction was seen using GST-
AR-(220–270m4), in which four mutations (L237A/K239M/
V241A/V243A) were introduced into the NH2-terminal con-
served motif (Fig. 3C).
The data indicate a direct interaction between AR and CHIP
mediated by the short AR NH2-terminal fragment that con-
tains the conserved motif. A reduced AR and CHIP interaction
by AR mutations derived from the TRAMP model suggests that
the AR NH2-terminal conserved motif functions to limit AR
activity and that mutations in this region confer increased AR
activity, which contributes to prostate cancer growth. However,
unlike the transcriptional activity detected in this region that
depended on four conserved residues of the NH2-terminal con-
served motif, the AR and CHIP interaction was not diminished
by the L237A/K239M/V241A/V243A mutations.
CHIP-induced Inhibition of AR Transcriptional Activity and
AR Steady-state Levels—Coexpression of full-length CHIP de-
creased both AR and GR transcriptional activity (Fig. 4A). This
is in contrast to the activity observed without any further DNA
addition, with coexpression of the pCMV5 empty vector control,
or with coexpression of the CHIP mutant lacking the TPR
domain (CHIPTPR) (Fig. 4A, TP). Surprisingly, deletion of
the conserved sequence in AR234–247 or AR220–270 did
not eliminate the inhibitory effect of CHIP on AR transactiva-
tion (data not shown). Furthermore, the constitutive transcrip-
tional activities of AR truncation mutant AR-(1–660), which5 C. Patterson, unpublished data.
the AR NH2-terminal conserved motif; lanes 5–9), and GST-AR-(220–270m4) (with the L237A/K239M/V241A/V243A mutations; lanes 9–12). 30%
Input (lanes 13–16) represents 30% of total 35S-labeled CHIP or CHIP mutant used in the reactions and had the following band intensities,
indicating similar protein loading: 166 integrated optical units (lane 13), 180 (lane 14), 162 (lane 15), and 173 (lane 16). Radiolabeled bands detected
by exposure to x-ray film indicate 35S-labeled CHIP interaction with GST-AR-(220–270) and GST-AR-(220–270m4). D, reduction in the in vitro
interaction between CHIP and the AR NH2-terminal conserved motif by AR mutations from the TRAMP model for prostate cancer.
35S-Labeled
full-length wild-type CHIP and CHIPTPR were incubated with GST (GST0), GST-AR-(220–270), GST-AR-(220–270)-E236G, or GST-AR-(220–
270)-A234T as indicated. 30% Input (lanes 9 and 10) represent 30% of total 35S-labeled CHIP used in the reactions and had band intensities of 106
(lane 9) and 112 (lane 10). Radiolabeled band intensities detected by exposure to x-ray film for the 35S-labeled CHIP interaction were 58 for
wild-type GST-AR-(220–270) (lane 3), 33 for GST-AR-(220–270)-E236G (lane 5), and 49 for GST-AR-(220–270)-A234T (lane 7). The data are
representative of three independent experiments.
FIG. 4. Effect of CHIP on transcriptional activity and AR
steady-state levels. A, HepG2 cells (0.2  105/well of a 12-well plate)
were transiently transfected as described under “Materials and Meth-
ods” with 0.25 g of MMTV-Luc/well using Effectene in the presence of
(per well) 50 ng of pCMV-hAR (AR), 50 ng of pCMV-hGR (GR), 10 ng of
pCMV-AR-(1–660), or 10 ng pCMV-AR-(1–660)234–247, together
with no further addition (), the pCMV5 empty vector (p5), pCMV5-
CHIP (C), or pCMV5-CHIPTPR (TP). Cells were incubated for 24 h
in the absence of hormone, with 0.1 nM R1881 for AR, or with 10 nM
dexamethasone for GR. B, shown is an immunoblot of AR coexpressed
with CHIP and the CHIP mutant lacking the TPR domain. COS cells
were transiently transfected using Effectene as described under “Ma-
terials and Methods” with 1 g of pCMV-hAR in the presence of 1 g of
pCMV5 empty vector (lanes 1 and 2), 1 g of pCMV5-CHIP (lanes 2 and
3), and pCMV5-CHIPTPR (lanes 5 and 6). Cells were incubated 24 h
after transfection in the absence and presence of 50 nM DHT as indi-
cated, harvested, and analyzed by immunoblotting using antibody
AR32 as described under “Materials and Methods.” Immunoblots of
parallel experiments using mouse anti--actin monoclonal antibody
(1:2500 dilution; Abcam, Inc.) confirmed similar protein loading be-
tween the lanes (data not shown). The data are representative of three
independent experiments.
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lacks the ligand-binding domain, and AR-(1–660)234–247,
which lacks, in addition, the NH2-terminal conserved motif,
were both strongly inhibited by CHIP (Fig. 4A). That this
inhibitory effect of CHIP was mediated by sequences outside of
the NH2-terminal conserved motif was also supported by our
observations that CHIP inhibited, to a similar extent, transac-
tivation by the progesterone receptor, a receptor that lacks the
conserved motif (data not shown). When the activity of a
pCMV-Luc constitutive reporter was tested in the presence of
CHIP expression, there was no significant decrease in tran-
scriptional activity above that observed with the empty vector
control or with pCMV5-CHIPTPR (data now shown), suggest-
ing that the inhibitory effect of CHIP is not due to inhibition of
general transcription mechanisms.
The results indicate that CHIP strongly represses AR and
GR transcriptional activity independent of the NH2-terminal
conserved motif and independent of the ligand-binding domain.
This is despite the interaction mediated by the AR NH2-termi-
nal conserved motif and CHIP. The requirement for the TPR
domain of CHIP for transcriptional repression of AR, AR-(1–
660), and GR suggests that the heat shock protein heterocom-
plex is involved since the CHIP TPR domain binds heat shock
proteins Hsp70 and Hsp90 (31). CHIP may modulate AR and
GR transcriptional activity through mechanisms independent
of the NH2-terminal conserved motif.
The influence of CHIP on AR steady-state levels was also
tested. The low level of AR detected in the absence of androgen
was further reduced by coexpression of CHIP (Fig. 4B, lanes 1
and 3). CHIP also decreased the stabilizing influence of androgen
on AR levels (lanes 2 and 4). In contrast, deletion of the CHIP
TPR region eliminated the reduction in AR levels induced by
coexpression of CHIP. The results indicate that the TPR region of
CHIP is required for the inhibitory effects of CHIP on AR steady-
state levels and AR transcriptional activity.
Colocalization of CHIP and AR—The subcellular localization
of CHIP and AR was determined in the absence and presence of
DHT by immunocytochemistry. In the absence of DHT, tran-
siently expressed AR (green) and FLAG-tagged CHIP (red)
localized in the cytoplasm, with no evidence of nuclear staining
(Fig. 5A). This is in agreement with a previous report that
CHIP is a cytoplasmic protein (23). The partial colocalization of
CHIP and AR in the cytoplasm supports their interaction in the
absence of hormone. In the presence of DHT, AR was nuclear,
whereas CHIP remained primarily in the cytoplasm (Fig. 5B).
The data suggest that CHIP regulates AR degradation prior to
androgen binding and that androgen-induced nuclear targeting
sequesters AR from the inhibitory effects of CHIP.
DISCUSSION
The NH2-terminal regions of steroid receptors lack strict struc-
tural requirements like those of the DNA- and ligand-binding
domains. To address structure-function relationships of the AR
NH2-terminal domain, we searched for evolutionarily conserved
sequences that predict a critical role in AR function. Our ap-
proach was based in part on studies of the AR NH2-terminal
FXXLF motif, which is one of few highly conserved regions in the
AR NH2-terminal domain (32). The FXXLF motif has a dominant
role in the androgen-dependent interdomain NH2- and COOH-
terminal interaction required for AR function, whereas the less
well conserved AR NH2-terminal WXXLF motif contributes only
weakly to the AR NH2- and COOH-terminal interaction (18, 32).
Considering its essential role in transcriptional activation, it is
surprising that more of the AR NH2-terminal domain is not
conserved (6). In particular, the two major activation regions of
AF1 lack significant sequence conservation across species. This
suggests that the NH2-terminal activation domain has evolved in
parallel with its interacting partners, with one interacting part-
ner being the AR COOH-terminal ligand-binding domain. In
contrast to the NH2-terminal region, the COOH-terminal region
including AF2 is structurally conserved. AF2 interacts with the
LXXLL motifs of p160 coactivators (33–36) and, for AR, interacts
in addition with the FXXLF motif that is present in the AR
NH2-terminal region (16, 18) and in some AR coregulators (19,
37, 38).
In this study, we have identified an extraordinarily con-
served 14-amino acid NH2-terminal sequence at human AR
amino acid residues 234–247 that is common to all published
sequences of AR, including the lower vertebrate fish species.
The conserved motif lacks intrinsic transcriptional activity per
se, but contributes to the transcriptional response of a larger
region between residues 220 and 270. The AR NH2-terminal
conserved motif lies within a previously described -helical
region (2) and is NH2-terminal to a recently reported hydro-
phobic motif identified among cellular and viral transcription
factors that act as binding sites for transcription factor TFIIF
(14), a general transcription factor reported to interact with AR
(39, 40). To study the function of the AR NH2-terminal con-
served motif, we performed a yeast two-hybrid screen and
FIG. 5. Immunocytochemistry of
CHIP and AR. COS cells were tran-
siently transfected with pCMV-FLAG-
CHIP and pCMV-hAR. Immunostaining
was detected after incubation in the ab-
sence (A) and presence (B) of 100 nM DHT
as described under “Materials and Meth-
ods.” Shown is green fluorescence for AR
(left panels), red fluorescence for FLAG-
CHIP (middle panels), and the merged
images (right panels).
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identified CHIP as the interacting partner for the conserved
AR NH2-terminal conserved motif. CHIP is highly conserved
across species and interacts with the NH2-terminal motif that
is conserved throughout the entire AR gene family. Coexpres-
sion studies have shown that CHIP limits AR function by
promoting AR degradation most likely through the previously
described role of CHIP in ubiquitylation (13).
CHIP, named for its interaction with Hsp70, was originally
identified from a screen for TPR domains. The TPR, first de-
scribed in yeast proteins (41, 42), is a tandem 34-amino acid
repeat composed of antiparallel -helices (30). The TPR do-
mains of CHIP mediate its interaction with Hsp90 and Hsp70
to redirect incompletely folded proteins for degradation (31).
TPR protein interaction surfaces on the chaperone cofactors
Hip (Hsp70-interacting protein) (43) and Hop (Hsp90/Hsp70-
organizing protein) (44) interact with the COOH-terminal
EEVD motif of Hsp70 and Hsp90 during the chaperone hetero-
complex formation that mediates protein folding (30, 45, 46).
CHIP inhibits Hsp70 ATPase and protein refolding activities,
although paradoxically, its overexpression increases chaperone
activity (47). CHIP contains a U-box domain at its COOH
terminus (25). Structurally similar to a RING finger domain,
U-box-containing proteins are a third group of ubiquitin ligases
with E3 activity that direct ubiquitylation of chaperone protein
complex substrates, leading to increased degradation by the
proteasome (24, 26, 48). CHIP was shown to promote ubiqui-
tylation and degradation through the proteasome of GR (31),
AR (13), and other proteins (26, 49), including ErbB2/Neu (50,
51). However, it was previously suggested that the predomi-
nant effect of CHIP on AR is inhibition of protein folding and
reduced degradation (13). CHIP may act as a molecular link
between the protein folding chaperone functions and protea-
some-mediated protein degradation processes of the
Hsp70Hsp90 heterocomplex (52). CHIP also directly modu-
lates the stress response by activating heat shock factor-1 (53)
and influences protein trafficking (54).
A direct interaction between CHIP and the AR NH2-terminal
conserved motif was confirmed in mammalian two-hybrid and
GST affinity matrix binding assays, supporting the initial iden-
tification of CHIP in a yeast two-hybrid screen as a bona fide
AR-interacting protein. A BLAST search of the protein data
base showed that besides AR, GR from Xenopus and higher
species is the only other protein that contains a homologous
sequence. However, in the yeast two-hybrid interaction assay,
CHIP did not interact with a GR fragment containing the
partial sequence (data not shown), even though CHIP de-
creased GR transcriptional activity to an extent similar to the
decrease in AR activity. It is conceivable that CHIP also asso-
ciates with AR and GR indirectly via the ligand-binding do-
main through an association with Hsp70 and Hsp90. The re-
quirement of the TPR region of CHIP for inhibition of AR and
GR transcriptional activity suggests a mechanism involving
CHIP interaction with the heat shock protein complex. The
ARCHIPHsp complex may be further stabilized by the NH2-
terminal conserved motif. On the other hand, CHIP also de-
creased the transcriptional activity of an AR deletion mutant
lacking the ligand-binding domain, and deletion of the con-
served sequence did not eliminate the inhibitory effect. The
lack of a requirement for the AR NH2-terminal conserved motif
and the ligand-binding domain for the inhibitory effect of CHIP
on AR transactivation suggests that other factors are involved.
Our immunostaining results show that, in the absence of
androgen, AR and CHIP partially colocalized in the cytoplasm.
The addition of DHT translocated AR to the nucleus, but CHIP
remained predominantly cytoplasmic. The data suggest the
model shown in Fig. 6, whereby CHIP, in association with the
heat shock protein complex, targets AR for degradation in the
cytoplasm prior to hormone binding, thereby contributing to
the rapid turnover of AR in the absence of ligand (55). Ligand-
induced targeting of AR to the nucleus would favor its stabili-
zation not only by sequestering it in the nuclear compartment
away from CHIP, but also by the androgen-induced interdo-
main AR NH2- and COOH-terminal interaction that increases
AR stabilization (56, 57). The subcellular segregation of CHIP
and androgen-bound AR provides an additional mechanism for
AR stabilization subsequent to hormone binding.
A requirement for Hsp90 in androgen binding to AR was
reported previously (27). Geldanamycin, an inhibitor of the
Hsp90 chaperone function (58), inhibits androgen binding, in-
creases AR degradation, and inhibits AR functional activity
(27, 59). CHIP was reported to decrease AR synthesis, to inhibit
folding of AR by actions not involving its E3 activity, and to
reduce AR degradation (13). The studies reported here support
that CHIP increases AR degradation in the absence and pres-
ence of androgen. This is consistent with a previous study
showing that CHIP promotes ubiquitylation of AR, but conflicts
with observations that CHIP does not increase AR degradation
(13). A region at human AR residues 11–172, which is NH2-
terminal to the conserved AR motif, was also reported to inter-
act with a different ubiquitin ligase, a RING domain-contain-
ing protein called AR-NIP (AR NH2 terminus-interacting
protein) (12).
Several spontaneous somatic AR mutations were reported in
the TRAMP model of prostate cancer during tumor progres-
sion, two of which (E236G and A234T) are within the AR
NH2-terminal conserved motif. TRAMP tumors were derived in
transgenic mice in response to overexpression of the SV40 large
and small tumor antigens under the control of the minimal
426 to 28 regulatory sequence of the prostate-specific rat
probasin promoter (60). The interaction between AR and CHIP
was reduced as a result of these AR mutations. This is in
support of the AR NH2-terminal conserved motif functioning to
limit AR activity. Interference with the AR and CHIP interac-
FIG. 6. Model of the functional relationship between AR and
CHIP. The data suggest that AR and CHIP interact in the cytoplasm
prior to androgen binding. This interaction contributes to AR degrada-
tion, resulting in reduced AR-mediated transcriptional activity. The
requirement for the TPR and U-box domains of CHIP in its interaction
with AR suggests a role for the heat shock protein complex that includes
Hsp70 and Hsp90. Hormone binding induces AR translocation to the
nucleus and results in subcellular segregation of CHIP and androgen-
bound AR. This provides an additional mechanism for AR stabilization.
Binding of AR to response element DNA present in androgen-respon-
sive genes is thought to occur as an antiparallel dimer.
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tion would be expected to increase AR activity, which could lead
to increased prostate cancer growth. In agreement with this,
recent studies have shown that the E236G mutation, which we
found inhibited the AR and CHIP interaction to the greatest
extent, is associated with an increased incidence of tumor for-
mation when the AR mutant is overexpressed.6 Furthermore, it
was reported that the E236G mutant increases AR transacti-
vation in the presence of AR coactivators (17). The results
support the inhibitory role of the AR NH2-terminal conserved
motif mediated by CHIP. With the recent report of increased
AR levels as a common feature of hormone refractory recurrent
prostate cancer (61), down-regulation of or mutations in CHIP
may contribute to increased AR steady-state levels during pros-
tate cancer progression.
However, increased degradation of AR cannot necessarily be
construed as a decrease in AR functional activity. In many
instances, ligand-activated transcription factors are rapidly
degraded. Among the steroid receptors, AR (55) and the vita-
min D receptor (62) are exceptions. AR is distinguished by its
rapid degradation in the absence of ligand (55) and androgen-
induced stabilization (56). Part of the mechanism for androgen-
induced AR stabilization involves the androgen-dependent
NH2- and COOH-terminal interaction (57, 63) mediated by the
FXXLF and WXXLF motifs mentioned above (18, 21). It is
plausible that through the interaction of CHIP and the AR
NH2-terminal conserved motif, CHIP helps to maintain low
levels of AR in normal cells. We have shown that CHIP is
mainly in the cytoplasm, and CHIP has been reported to be
highly expressed in non-proliferating cells (23). In contrast to
the low level of AR in non-proliferating cells, AR levels in
prostate cancer are elevated (61), and AR has increased stabil-
ity, which results in a greater sensitivity to low levels of circu-
lating androgen (64) or to androgens present in prostate cancer
tissue (65). It is possible that nuclear localization of AR that is
detected in prostate cancer cells in the absence of androgen (66)
contributes to increased AR levels by sequestering AR in the
nucleus away from the degrading influence of CHIP in the
cytoplasm. Alterations in CHIP levels, mutations in CHIP, or,
as shown here, mutations in AR could decrease AR degrada-
tion, resulting in increased AR-dependent proliferation of re-
current prostate cancer cells.
Sequence homology comparisons in the AR gene family show
that Ser256 in human and rat AR replaces the negatively
charged residue aspartic or glutamic acid in AR from lower
species. Phosphorylation at Ser256 was reported for human AR
(10) and effectively reintroduces the constitutive negative
charge present in lower species. The proximity of Ser256 to the
NH2-terminal conserved motif suggests that a negative charge
at this position modulates protein interactions at the NH2-
terminal conserved motif and that phosphorylation at this site
is a regulatory switch. Although the interaction between CHIP
and AR was not significantly influenced by the S256A and
S256D mutations in mammalian two-hybrid assays, the tran-
sition from the constitutive negative charge of lower species to
the conditional charge regulated by phosphorylation may in-
fluence other interacting partners at this site. Higher verte-
brates gain the ability to regulate the negative charge by phos-
phorylation. This is also suggested by the human AR
phosphorylation site Ser650 (8, 10), which is Asp in lower spe-
cies. Similarly, the human estrogen receptor- phosphorylation
site Ser118 (67, 68) is Asp in the lamprey estrogen receptor (4).
Increased regulation introduced by phosphorylation likely
helps to modulate protein interactions to increase the overall
level of homeostatic control.
NH2-terminal domains of steroid receptors are largely un-
structured, and amino acid sequence is poorly conserved; yet
computational programs that predict protein structure can
identify short 20-amino acid residue segments with ordered
secondary structure, some of which are conserved across spe-
cies. The PONDR Protein Disorder Predictor indicates that the
FXXLF and WXXLF motifs are structured, and similarly, an
ordered amphipathic -helical structure is predicted for the AR
NH2-terminal conserved motif described in this work. We de-
signed a yeast two-hybrid screening approach based on se-
quence conservation and structure predictions that short or-
dered regions, especially amphipathic -helices, are surfaces
for protein-protein interactions. In support of this, the highly
conserved AR FXXLF motif and flanking sequence mediate the
androgen-dependent interaction with AF2 in the ligand-bind-
ing domain (18, 21) and the interaction of coregulatory proteins
(19, 38). The predicted amphipathic -helices of the p160 coac-
tivator LXXLL motifs were also confirmed by structural studies
(69, 70). Thus, although transcriptional activation domains of
regulatory proteins are largely unstructured and not con-
served, short segments within these regions are predicted to
form amphipathic -helices whose structure is likely stabilized
by binding coregulatory proteins (2, 71). We previously pro-
posed a reversal of the acidic transcriptional activation do-
main-coactivator interaction model, implicating charge inter-
actions that precede nonpolar contacts of hydrophobic residues
in protein-protein interactions mediated by amphipathic -hel-
ices (21). In the present study, we used comparative sequence
alignment and structure predictions to identify a 14-amino acid
AR NH2-terminal conserved motif conserved in all AR se-
quences throughout the lower vertebrates. We have demon-
strated the usefulness of yeast two-hybrid library screening
using short 50-amino acid fusion peptides containing con-
served sequence and predicted structure in the identification of
interacting partners. The results demonstrate a novel strategy
to identify interacting partners and to probe the functional
significance of short conserved sequences present in steroid
receptor NH2-terminal domains.
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